Largest biotechnology: pharmaceutical preparations companies — Page 5
Every US-listed biotechnology: pharmaceutical preparations company we cover, 500 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$5.202 T
5.3% of all US-listed value
Companies
500
Ranked #5 of 152 industries
Average
$10.404 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 401 | AEON BiopharmaAEON | $14.2M | $0.24 | +3.76% | United States |
| 402 | Radiopharm TheranosticsRADX | $14.2M | $0.98 | -1.13% | Australia |
| 403 | Allarity TherapeuticsALLR | $14.0M | $0.88 | +0.43% | United States |
| 404 | Tvardi TherapeuticsTVRD | $13.6M | $1.02 | +2.82% | United States |
| 405 | Dare BioscienceDARE | $13.5M | $0.69 | -0.14% | United States |
| 406 | Actuate TherapeuticsACTU | $13.5M | $0.56 | -8.75% | United States |
| 407 | LipocineLPCN | $13.2M | $1.60 | -1.24% | United States |
| 408 | Rocket OneRKTO | $13.1M | $0.53 | -1.11% | United States |
| 409 | VyomeHIND | $12.9M | $1.84 | +0.00% | United States |
| 410 | Aspire-LakewoodASBP | $12.4M | $8.85 | +1.49% | United States |
| 411 | Cellectar BiosciencesCLRB | $12.1M | $1.28 | +4.07% | United States |
| 412 | BiofronteraBFRI | $11.9M | $0.80 | -0.50% | United States |
| 413 | Lisata TherapeuticsLSTA | $11.3M | $1.05 | +0.96% | United States |
| 414 | GT BiopharmaGTBP | $11.2M | $5.41 | -25.99% | United States |
| 415 | BiovieBIVI | $10.9M | $1.26 | +1.61% | United States |
| 416 | CytoMed TherapeuticsGDTC | $10.9M | $0.92 | +5.45% | Singapore |
| 417 | Citius PharmaceuticalsCTXR | $10.9M | $0.40 | -5.27% | United States |
| 418 | Adial PharmaceuticalsADIL | $10.8M | $4.11 | +7.59% | United States |
| 419 | Alaunos TherapeuticsTCRT | $10.6M | $3.08 | +3.70% | United States |
| 420 | BioLineRxBLRX | $10.5M | $2.11 | -4.72% | Israel |
| 421 | Phio PharmaceuticalsPHIO | $10.4M | $0.89 | +0.31% | United States |
| 422 | Kiora PharmaceuticalsKPRX | $10.4M | $2.34 | +0.43% | United States |
| 423 | Lantern PharmaLTRN | $10.2M | $0.68 | +4.28% | United States |
| 424 | Ensysce BiosciencesENSC | $10.1M | $0.52 | +4.29% | United States |
| 425 | Palatin TechnologiesPTN | $9.88M | $5.55 | +0.54% | United States |
| 426 | Karyopharm TherapeuticsKPTI | $9.63M | $0.42 | +18.35% | United States |
| 427 | BullFrog AIBFRG | $9.57M | $0.52 | +4.96% | United States |
| 428 | Chemomab TherapeuticsCMMB | $9.26M | $1.15 | -2.54% | Israel |
| 429 | Theriva BiologicsTOVX | $9.02M | $0.20 | -5.48% | United States |
| 430 | Tempest TherapeuticsTPST | $8.92M | $0.53 | -8.33% | United States |
| 431 | MetaViaMTVA | $8.83M | $1.34 | +3.88% | United States |
| 432 | Vistagen TherapeuticsVTGN | $8.59M | $0.19 | -2.12% | United States |
| 433 | Bolt BiotherapeuticsBOLT | $7.98M | $4.14 | -3.94% | United States |
| 434 | Curanex PharmaceuticalsCURX | $7.86M | $5.01 | +5.14% | United States |
| 435 | CalciMedicaCALC | $7.85M | $1.15 | +7.98% | United States |
| 436 | ImmuronIMRN | $7.83M | $0.97 | -4.90% | Australia |
| 437 | SoligenixSNGX | $7.62M | $0.35 | -1.27% | United States |
| 438 | InMed PharmaceuticalsINM | $7.47M | $1.36 | +1.49% | Canada |
| 439 | Skye BioscienceSKYE | $7.22M | $1.63 | +0.62% | United States |
| 440 | Aprea TherapeuticsAPRE | $7.05M | $0.56 | -0.16% | United States |
| 441 | CNS PharmaceuticalsCNSP | $7.05M | $4.83 | -3.31% | United States |
| 442 | Enveric BiosciencesENVB | $6.76M | $1.51 | +4.86% | United States |
| 443 | FibroBiologicsFBLG | $6.74M | $0.99 | +7.95% | United States |
| 444 | ImunonIMNN | $6.68M | $1.19 | +18.41% | United States |
| 445 | Moleculin BiotechMBRX | $6.63M | $6.31 | +1.94% | United States |
| 446 | Bio Green Med SolutionBGMS | $6.62M | $1.00 | +6.38% | United States |
| 447 | ExicureXCUR | $6.61M | $1.01 | +1.13% | United States |
| 448 | Acurx PharmaceuticalsACXP | $6.39M | $1.15 | +0.88% | United States |
| 449 | Alzamend NeuroALZN | $6.03M | $1.25 | -3.85% | United States |
| 450 | Lexaria BioscienceLEXX | $5.94M | $2.82 | +6.42% | Canada |
| 451 | Traws PharmaTRAW | $5.78M | $0.38 | -0.19% | United States |
| 452 | PulmatrixPULM | $5.73M | $1.57 | +9.79% | United States |
| 453 | Can-Fite BioPharmaCANF | $5.73M | $1.89 | -0.02% | Israel |
| 454 | Addex TherapeuticsADXN | $5.09M | $2.99 | -1.97% | Switzerland |
| 455 | Medicus PharmaMDCX | $5.07M | $2.68 | -1.47% | Canada |
| 456 | Apimeds Pharmaceuticals USAPUS | $5.01M | $3.25 | -4.69% | United States |
| 457 | Processa PharmaceuticalsPCSA | $4.92M | $1.76 | -1.68% | United States |
| 458 | NeuroSense TherapeuticsNRSN | $4.86M | $2.56 | +7.11% | Israel |
| 459 | ScientureSCNX | $4.77M | $2.91 | -4.75% | United States |
| 460 | Xenetic BiosciencesXBIO | $4.73M | $2.02 | +1.00% | United States |
| 461 | GelteqGELS | $4.71M | $0.44 | -1.83% | Australia |
| 462 | Xtl BiopharmaceuticalsXTLB | $4.60M | $1.87 | -3.61% | Israel |
| 463 | LongeveronLGVN | $4.56M | $1.43 | -4.67% | United States |
| 464 | RedHill BiopharmaRDHL | $4.04M | $0.46 | -10.31% | Israel |
| 465 | EnlivexENLV | $4.03M | $0.20 | -9.61% | Israel |
| 466 | NuCanaNCNA | $4.00M | $0.96 | -4.33% | United Kingdom |
| 467 | Dermata TherapeuticsDRMA | $3.96M | $0.80 | -8.09% | United States |
| 468 | Kala BioKALA | $3.69M | $0.19 | +0.58% | United States |
| 469 | Jupiter NeurosciencesJUNS | $3.67M | $2.78 | -0.71% | United States |
| 470 | Cadrenal TherapeuticsCVKD | $3.64M | $1.02 | -1.92% | United States |
| 471 | Ernexa TherapeuticsERNA | $3.44M | $2.11 | -5.80% | United States |
| 472 | Sunshine BiopharmaSBFM | $3.28M | $0.22 | -2.09% | Canada |
| 473 | Propanc BiopharmaPPCB | $3.26M | $0.32 | -1.75% | Australia |
| 474 | Galmed PharmaceuticalsEOCN | $3.25M | $3.12 | +1.60% | Israel |
| 475 | GRI BioGRI | $3.21M | $1.47 | +0.69% | United States |
| 476 | 60 Degrees PharmaceuticalsSXTP | $3.13M | $0.89 | -3.49% | United States |
| 477 | Clearmind MedicineCMND | $3.01M | $5.94 | -2.94% | Canada |
| 478 | Mustang BioMBIO | $2.90M | $0.38 | +0.87% | United States |
| 479 | Aptevo TherapeuticsAPVO | $2.88M | $1.60 | -0.93% | United States |
| 480 | PRF TechnologiesPRFX | $2.67M | $0.76 | +5.44% | Israel |
| 481 | Lunai BioworksLNAI | $2.61M | $0.52 | +0.58% | United States |
| 482 | HCW BiologicsHCWB | $2.59M | $1.16 | -0.85% | United States |
| 483 | Decoy TherapeuticsDCOY | $2.55M | $1.07 | -5.73% | United States |
| 484 | GeoVax LabsGOVX | $2.35M | $0.23 | +2.25% | United States |
| 485 | Silo PharmaSILO | $2.28M | $1.20 | +0.00% | United States |
| 486 | OnconetixONCO | $2.28M | $0.44 | +7.09% | United States |
| 487 | PMGCELAB | $2.25M | $2.78 | -1.07% | United States |
| 488 | Revelation BiosciencesREVB | $2.05M | $3.60 | -4.00% | United States |
| 489 | Kairos PharmaKAPA | $1.95M | $0.58 | -1.22% | United States |
| 490 | Purple BiotechPPBT | $1.87M | $1.15 | +5.99% | Israel |
| 491 | OragenicsOGEN | $1.86M | $0.41 | -4.88% | United States |
| 492 | Biodexa PharmaceuticalsBDRX | $1.76M | $0.42 | +8.89% | United Kingdom |
| 493 | XORTX TherapeuticsXRTX | $1.69M | $0.93 | -2.66% | Canada |
| 494 | GenprexGNPX | $1.68M | $2.05 | -3.76% | United States |
| 495 | Matinas BioPharmaMTNB | $1.49M | $1.52 | -10.59% | United States |
| 496 | Artelo BiosciencesARTL | $1.40M | $2.56 | -2.29% | United States |
| 497 | Lakewood-Amedex BiotherapeuticsLABT | $1.10M | $0.47 | -19.31% | United States |
| 498 | SciSparcSPRC | $778.5K | $1.34 | +0.75% | Israel |
| 499 | China SXT PharmaceuticalsSXTC | $756.1K | $0.07 | +11.79% | China |
| 500 | CDT EquityCDT | $162.7K | $0.14 | -8.99% | United States |
Showing 401–500 of 500 companies. One row per company, with secondary share classes folded into their primary listing. Updated 23 Oct 2026.
Sectors biotechnology: pharmaceutical preparations companies sit in
Other industries
Semiconductors 100Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 233Computer Manufacturing 10Major Banks 243Industrial Machinery/Components 210Catalog/Specialty Distribution 30Business Services 92Commercial Banks 35Integrated oil Companies 16Auto Manufacturing 29Oil & Gas Production 116Investment Bankers/Brokers/Service 69Department/Specialty Retail Stores 13Real Estate Investment Trusts 175Beverages (Production/Distribution) 36Telecommunications Equipment 84Electric Utilities: Central 61Finance: Consumer Services 165Electronic Components 20Biotechnology: Biological Products (No Diagnostic Substances) 162Medical Specialities 44Consumer Electronics/Appliances 23Property-Casualty Insurers 68All industries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.